Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
278.36
-0.34 (-0.12%)
Nov 18, 2026, 9:43 AM EST - Market open
Johnson & Johnson Market Cap
Johnson & Johnson has a market cap or net worth of $670.1 billion as of November 18, 2026. It is the 20th most valuable company in the world and the 17th biggest in the United States. Its market cap has increased by 39.36% in one year.
Market Cap
670.10B
Enterprise Value
697.52B
1-Year Change
39.36%
Global Rank
Country Rank
#17 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Johnson & Johnson's market cap has increased from $108.92B to $670.10B, an increase of 515.23%. That is a compound annual growth rate of 6.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 670.10B | 34.40% |
| Dec 31, 2025 | 498.60B | 43.20% |
| Dec 31, 2024 | 348.19B | -7.72% |
| Dec 29, 2023 | 377.32B | -18.30% |
| Dec 30, 2022 | 461.85B | 2.55% |
| Dec 31, 2021 | 450.36B | 8.70% |
| Dec 31, 2020 | 414.31B | 7.92% |
| Dec 31, 2019 | 383.91B | 10.92% |
| Dec 31, 2018 | 346.11B | -7.79% |
| Dec 29, 2017 | 375.36B | 19.76% |
| Dec 30, 2016 | 313.43B | 10.28% |
| Dec 31, 2015 | 284.22B | -2.90% |
| Dec 31, 2014 | 292.70B | 13.27% |
| Dec 31, 2013 | 258.42B | 33.02% |
| Dec 31, 2012 | 194.27B | 8.47% |
| Dec 30, 2011 | 179.09B | 5.44% |
| Dec 31, 2010 | 169.86B | -4.42% |
| Dec 31, 2009 | 177.71B | 7.05% |
| Dec 31, 2008 | 166.00B | -13.03% |
| Dec 31, 2007 | 190.88B | -0.28% |
| Dec 29, 2006 | 191.42B | 7.06% |
| Dec 30, 2005 | 178.79B | -5.00% |
| Dec 31, 2004 | 188.21B | 22.75% |
| Dec 31, 2003 | 153.33B | -3.90% |
| Dec 31, 2002 | 159.55B | -11.43% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 1.28T |
| AbbVie | 520.65B |
| Merck & Co. | 356.13B |
| Novartis AG | 305.45B |
| AstraZeneca | 287.09B |
| Amgen | 250.07B |
| Gilead Sciences | 207.86B |
| Novo Nordisk | 185.23B |